The European Society of Cardiology (ESC) through the ESC Council of Cardio-Oncology will host on October 19th the first multi-stakeholder meeting in the context theRESILIENCE project, funded by the European Commission, to share the latest resultswith different stakeholders and patients.
The event will focus on emerging therapies for cancer therapy induced cardiotoxicityand will gather a wide number of members of the RESILIENCE consortium along with world leaders in the field of cardio-oncology, industry, specialized press, patients and patient organizations, expecting to gathering together about 100 attendees.
Fully on-site, the event will take place at the European Heart House in Nice and it will be opened by Borja Ibáñez, Scientific Coordinator of RESILIENCE and Scientific Director at CNIC; Teresa López-Fernández, Chair-elected of the ESC Council of Cardio-Oncology; and Riccardo Asteggiano, Past Chair-person of the ESC Council of Cardio-Oncology. Among other topics, the speakers will discuss the ESC Guidelines on cardio-oncology and clinical trials from different perspectives. The event will also give voice to the experience of the patients and discuss with the scientists the progress of the study and the state of the art in the field of cardiotoxicity.
A preliminary draft of the agenda is available here:
If you want to attend this event, please register here.
For more information, please contact Elsa Pacella, EU Projects Team Manager at the European Society of Cardiology at email@example.com
About the ESC Council of Cardio-Oncology and RESILIENCE
The Council, in collaboration with the ESC Advocacy Committee contributed to theEU’s Beating Cancer Plan through different joint initiatives at the EU level. It is in this context that the EU-funded project – RESILIENCE – was ideated, a naturalconsequence of these advocacy efforts. The ESC Council of Cardio-Oncology plays a crucial role in RESILIENCE as leader of the work package on dissemination and exploitation of results.